pembrolizumab,efineptakin alfa
merck,neoimmunetech
['pembro', 'efineptakin', 'neoimmune']
new data from our phase 2a clinical study nit-110 shows the clinical efficacy of nt-i7 (efineptakin alfa) when combined with pembrolizumab in checkpoint-inhibitor-na ve microsatellite stable #colorectalcancer and #pancreaticcancer! #sitc22 